APA

Pellicelli A. M., Montalbano M., Lionetti R., Durand C., Ferenci P., D'Offizi G., Knop V., Telese A., Lenci I., Andreoli A., Zeuzem S. & Angelico M. (20150513). Sofosbuvir plus daclatasvir for post-transplant recurrent hepatitis C: potent antiviral activity but no clinical benefit if treatment is given late. : Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Chicago

Pellicelli Adriano M, Montalbano Marzia, Lionetti Raffaella, Durand Christine, Ferenci Peter, D'Offizi Gianpiero, Knop Viola, Telese Andrea, Lenci Ilaria, Andreoli Arnaldo, Zeuzem Stefan and Angelico Mario. 20150513. Sofosbuvir plus daclatasvir for post-transplant recurrent hepatitis C: potent antiviral activity but no clinical benefit if treatment is given late. : Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Harvard

Pellicelli A. M., Montalbano M., Lionetti R., Durand C., Ferenci P., D'Offizi G., Knop V., Telese A., Lenci I., Andreoli A., Zeuzem S. and Angelico M. (20150513). Sofosbuvir plus daclatasvir for post-transplant recurrent hepatitis C: potent antiviral activity but no clinical benefit if treatment is given late. : Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

MLA

Pellicelli Adriano M, Montalbano Marzia, Lionetti Raffaella, Durand Christine, Ferenci Peter, D'Offizi Gianpiero, Knop Viola, Telese Andrea, Lenci Ilaria, Andreoli Arnaldo, Zeuzem Stefan and Angelico Mario. Sofosbuvir plus daclatasvir for post-transplant recurrent hepatitis C: potent antiviral activity but no clinical benefit if treatment is given late. : Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver. 20150513.